发明名称 Inhibitors of the Renal Outer Medullary Potassium Channel
摘要 The present invention provides compounds of Formula I;;and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention.
申请公布号 US2014288088(A1) 申请公布日期 2014.09.25
申请号 US201214353418 申请日期 2012.10.22
申请人 MERCK SHARP & DOHME CORP. 发明人 Tang Haifeng;Pio Barbara;Chobanian Harry R.
分类号 C07D405/14;A61K31/496;C07D409/14;C07D417/14;C07D495/04;C07D405/06;A61K45/06 主分类号 C07D405/14
代理机构 代理人
主权项 1. A compound having structural Formula I: or a pharmaceutically acceptable salt thereof wherein: Z1 is wherein the dashed bonds represent the optional presence of —C1-2alkanediyl- which, when present, forms a 5 to 6 membered carbocyclic ring which is fused to the aryl ring; Z2 is R1 is —H, —CH3, —CF3, —CHF2, —CH2F or —CH2OH; R2 is —H, oxo (═O) or —C1-6alkyl; R4 is —H, —OH, oxo or —C1-6alkyl; provided that when R4 is —OH or oxo, then R2 is not oxo; R3 and R5 are each independently —H or —C1-6alkyl; provided that R3 is absent when R2 is oxo, and R5 is absent when R4 is oxo; R1a is —H, halo or —C1-3alkyl; R1b is —H, halo, —C1-3alkyl, —O—C1-3alkyl or —COOC1-3alkyl; one of R2a and R2b is —CN and the other is —H or —C1-3alkyl; one of R2c and R2d is —SO2—C1-3alkyl and the other is —H or —C1-3alkyl; X1, X2, X3 and X4 are each independently CH or N, provided that only one of X1, X2, X3 or X4 is N; X5, X6 and X7 are each independently CH or N, provided that only one of X5, X6 or X7 is N; and Ra and Rb are each independently —H, halo, —C1-3alkyl, —O—C1-3 alkyl or —COOC1-3alkyl.
地址 Rahway NJ US